
- /
- Supported exchanges
- / MU
- / RGN.MU
Repligen Corporation (RGN MU) stock market data APIs
Repligen Corporation Financial Data Overview
There is no Profile data available for RGN.MU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Repligen Corporation data using free add-ons & libraries
Get Repligen Corporation Fundamental Data
Repligen Corporation Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2018-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Repligen Corporation News

Why Repligen (RGEN) Stock Is Down Today
What Happened? Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) fell 3.5% in the afternoon session after Jefferies lowered its price target on the stock. Analyst Matthew ...


Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 29% Undervaluation?
Key Insights The projected fair value for Repligen is US$167 based on 2 Stage Free Cash Flow to Equity Current share price of US$119 suggests Repligen is potentially 29% undervalued Analyst price tar...

Repligen, Revvity, Avantor, Fortrea, and Azenta Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Po...

Repligen Corporation to Present at Upcoming September Conferences
Repligen Corporation WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.